UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058237
Receipt number R000066201
Scientific Title Evaluation of the usefulness of an automatic pupil measurement device for diagnosing consciousness disorders in patients with acute drug poisoning: A single-center prospective observational study
Date of disclosure of the study information 2025/06/21
Last modified on 2025/06/20 13:43:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the evaluation of consciousness disorders in patients with acute drug poisoning using an automatic pupil measurement device

Acronym

Relationship between acute drug poisoning and pupil response

Scientific Title

Evaluation of the usefulness of an automatic pupil measurement device for diagnosing consciousness disorders in patients with acute drug poisoning: A single-center prospective observational study

Scientific Title:Acronym

Automated Detection of Awareness in Poisoned Toxicology patients: ADAPT STUDY

Region

Japan


Condition

Condition

Acute Drug Intoxication

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to use an automatic pupil measurement device in patients with acute drug poisoning to clarify the relationship between pupil response and the severity of consciousness impairment. Furthermore, we will examine the extent to which pupil response indicators (such as NPi) correlate with the severity of consciousness impairment, clinical outcomes, and organ dysfunction, and comprehensively evaluate the clinical utility of this device.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pupil response index measured by an automatic pupil measurement device

Key secondary outcomes

Consciousness impairment (Glasgow Coma Scale, JCS: Japan Coma Scale)
Correlation coefficient between pupil response indicators and Glasgow Coma Scale, Japan Coma Scale
Pupil diameter
Speed of light reflex
Oxygen administration
Presence of tongue base depression
Outcome (hospitalization, discharge, transfer, return home)
Length of stay in the intensive care unit
SOFA score
Types of medications administered, etc.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Cases diagnosed with acute drug poisoning or strongly suspected of acute drug poisoning who visited the emergency department.

Key exclusion criteria

Individuals under the age of 18
Individuals who did not consent to participate in the study
Cases where pupil response measurement was difficult for any reason (e.g., history of surgery, trauma, etc.)
Cases with obvious central nervous system disorders (e.g., cerebral hemorrhage, cerebral infarction, epilepsy, etc.)
Cases where pupil measurement using an automatic pupil measurement device was not performed prior to discharge or return home
Cases where consent to participate in the study was withdrawn
In cases of unexpected adverse events

Target sample size

60


Research contact person

Name of lead principal investigator

1st name RYUTO
Middle name
Last name YOKOYAMA

Organization

Yamagata University School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

9909585

Address

2-2-2 Iida Nishi, Yamagata City, Yamagata Prefecture

TEL

0236331122

Email

ryusi0311@gmail.com


Public contact

Name of contact person

1st name RYUTO
Middle name
Last name YOKOYAMA

Organization

Yamagata University School of Medicine

Division name

Department of Emergency and Critical Care Medicine

Zip code

9909585

Address

2-2-2 Iida Nishi, Yamagata City, Yamagata Prefecture

TEL

0236285422

Homepage URL


Email

ryusi0311@gmail.com


Sponsor or person

Institute

Yamagata Univercity

Institute

Department

Personal name



Funding Source

Organization

Yamagata Univercity

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Faculty of Medicine, Yamagata University

Address

2-2-2 Iida Nishi, Yamagata City, Yamagata Prefecture

Tel

0236331122

Email

yu-ikekenkyu@jm.kj.yamagata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 09 Day

Date of IRB

2025 Year 06 Month 20 Day

Anticipated trial start date

2025 Year 06 Month 22 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study Design
Case-Control Study
Patients who visited our facility between the date of approval and March 31 2028 and met the inclusion criteria
Primary Outcome
Measure Pupillary response index measured by an automatic pupillary measurement device
Secondary Outcome
Measures Impaired consciousness GCS JCS
Correlation coefficient between pupillary response index and GCS JCS
Pupillary diameter
Speed of light reflex
Presence or absence of oxygen administration
Presence or absence of tongue base depression
Outcome hospitalization discharge transfer return home
Length of stay in the intensive care unit
SOFA score
Types of medications administered etc

Inclusion criteria
Aged 18 years or older and under 100 years
Patients who visited the emergency department with a diagnosis or strong suspicion of acute drug poisoning

Exclusion criteria
Patients under 18 years of age
Individuals who did not consent to the study
Cases where pupil response measurement was difficult for any reason eg surgical history trauma history
Cases with obvious central nervous system disorders eg cerebral hemorrhage cerebral infarction epilepsy
Cases where pupil measurement using an automatic pupil measurement device was not performed prior to hospitalization or discharge


Management information

Registered date

2025 Year 06 Month 20 Day

Last modified on

2025 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066201